Kristin Reindel, PharmD
Specialty pharmacists and nurses at the University of Rochester Medical Center, in New York, improved pneumococcal vaccination practices among their patients with multiple sclerosis (MS) before starting infusion therapy, a new study showed.
The CDC recommends that patients given disease-modifying therapy such as ocrelizumab (Ocrevus, Genentech) and rituximab first get pneumococcal vaccinations to ensure optimal immune response, said Kristin Reindel, PharmD, a